PSCA-directed nanosized bio-immune conjugates (NANO:BICs) enable selective uptake of TLR9 agonists in bladder cancer cells. - Iltzsche M; Wetterling N; Jilek L; Nahhas D; Hesse M; Tietze S; Temme A; Thomas C; Fuessel S; Kind B (Frontiers in oncology, 2026)